Professur für Molekulare Mechanismen der Organfibrose

Reallocation / Closing: 30.09.2022


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGF? signalling (2015) Beyer C, Zenzmaier C, Palumbo-Zerr K, Mancuso R, Distler A, Dees C, Zerr P, et al. Journal article Inhibition of casein kinase II reduces TGF? induced fibroblast activation and ameliorates experimental fibrosis (2015) Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P, Palumbo K, et al. Journal article Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis (2015) Ruzehaji N, Avouac J, Elhai M, Frechet M, Frantz C, Ruiz B, Distler J, Allanore Y Journal article Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis (2015) Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Distler A, Gelse K, Distler O, et al. Journal article Vitamin D receptor regulates TGF-? signalling in systemic sclerosis (2015) Zerr P, Vollath S, Palumbo-Zerr K, Tomcik M, Huang J, Distler A, Beyer C, et al. Journal article Signature of circulating microRNAs in osteoarthritis (2015) Beyer C, Zampetaki A, Lin NY, Kleyer A, Perricone C, Iagnocco A, Distler A, et al. Journal article Autopsy versus clinical findings in patients with systemic sclerosis in a case series from patients of the EUSTAR database (2015) Sandmeier B, Jaeger VK, Nagy G, Carreira PE, Tzankov A, Widuchowska M, Antic M, et al. Journal article Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease (2015) Tomcik M, Zerr P, Palumbo-Zerr K, Storkanova H, Hulejova H, Spiritovic M, Kodet O, et al. Journal article Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database (2015) Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airò P, et al. Journal article Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group (2015) Jordan S, Distler J, Maurer B, Huscher D, Van Laar JM, Allanore Y, Distler O Journal article